Koninklijke Philips NV vs Sony Group Corp — how do they compare? Koninklijke Philips NV trades at $25.03 (market cap $24.84B), while Sony Group Corp trades at $23.54 (market cap $138.72B). The key difference: Sony Group Corp is far larger — about 5.6× Koninklijke Philips NV's market cap, and Koninklijke Philips NV pays the higher dividend (4.01%). Which is the better fit depends on your goals.
| PHG | SONY | |
|---|---|---|
Market Cap | $24.84B | $138.72B |
Sector | Health | Technology |
52-Week High | $32.91 | $30.26 |
52-Week Low | $25.02 | $19.32 |
Enterprise Value | $31.44B | $136.57B |
Dividend Yield | 4.01% | 0.67% |
Signals from Pluang's Aura AI — not financial advice
PHG trades at $25.29, down 2.32% today, with a bearish technical signal but strong recent earnings beats. The company reported Q2 2026 EPS of $0.57 versus $0.40 expected, continuing a trend of profitability after a turnaround from losses in prior years. Recent news highlights product launches in health technology and a $33.7 million award for AI-enabled stroke care (Business Wire, 2026-08-26).
The outlook is mixed: fundamentals show improving margins and cash flow, but technical indicators and a majority hold analyst rating suggest near-term caution. Key risks include competitive pressures and execution of growth initiatives, while institutional buying activity indicates underlying confidence.
Sony trades at $23.53, down 4.19% over 24 hours amid bearish technical signals. The company maintains strong operational cash flow of $2.32 trillion for 2025 and has beaten earnings expectations in two of the last three quarters. Analyst consensus remains bullish with 11 buy ratings versus 5 holds, though recent news highlights Sony's legal actions against Anthropic for copyright infringement and strategic focus on organic expansion over large-scale acquisitions.
The outlook is mixed: solid fundamentals and analyst support suggest long-term value, but near-term technical weakness and a projected net income decline to -$221.6 billion for 2026 pose risks. Investment opportunity lies in Sony's diversified entertainment ecosystem and content moat, while key risks include execution on profitability targets and competitive pressures in streaming and gaming.
Trailing returns across standard periods
Latest headlines on both assets
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →Sony Group is a conglomerate with consumer electronics roots, which not only designs, develops, produces, and sells electronic equipment and devices, but also is engaged in content businesses, such as console and mobile games, music, and movies. Sony is a global top company of CMOS image sensors, game consoles, professional broadcasting cameras, and music publishing, and is one of the top players on digital cameras, wireless earphones, recorded music, movies, and so on. Sony's business portfolio is well diversified with six major business segments. The company fully consolidated Sony Financial in September 2020, which provides life and non-life insurance, banking, and other financial services.
Read more on SONY →